GPM6B | Glycoprotein M6B | Predicted membrane proteins
| | | | | Tissue enriched |
GPR143 | G protein-coupled receptor 143 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Mixed |
GPR160 | G protein-coupled receptor 160 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
GPRC5B | G protein-coupled receptor, family C, group 5, member B | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GRIA1 | Glutamate receptor, ionotropic, AMPA 1 | FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
GRIA2 | Glutamate receptor, ionotropic, AMPA 2 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
GRIN2A | Glutamate receptor, ionotropic, N-methyl D-aspartate 2A | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
HGSNAT | Heparan-alpha-glucosaminide N-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
HVCN1 | Hydrogen voltage-gated channel 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ITPR1 | Inositol 1,4,5-trisphosphate receptor, type 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
KRTCAP3 | Keratinocyte associated protein 3 | Predicted membrane proteins
| | | | | Mixed |
LBR | Lamin B receptor | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MS4A8 | Membrane-spanning 4-domains, subfamily A, member 8 | Predicted membrane proteins
| | | | | Group enriched |
MT-ND3 | Mitochondrially encoded NADH dehydrogenase 3 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MTCH1 | Mitochondrial carrier 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
NDFIP1 | Nedd4 family interacting protein 1 | Predicted membrane proteins
| | | | | Expressed in all |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
OMA1 | OMA1 zinc metallopeptidase | Cancer-related genes Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
PEMT | Phosphatidylethanolamine N-methyltransferase | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
PIGN | Phosphatidylinositol glycan anchor biosynthesis, class N | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
POMT2 | Protein-O-mannosyltransferase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
POPDC2 | Popeye domain containing 2 | Predicted membrane proteins
| | | | | Tissue enriched |
PRAF2 | PRA1 domain family, member 2 | Predicted membrane proteins
| | | | | Expressed in all |
PSEN1 | Presenilin 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
PTCH1 | Patched 1 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
PTGES | Prostaglandin E synthase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
RER1 | Retention in endoplasmic reticulum sorting receptor 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
RHBG | Rh family, B glycoprotein (gene/pseudogene) | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
RHCG | Rh family, C glycoprotein | Predicted membrane proteins Transporters
| | | | | Group enriched |
RNFT2 | Ring finger protein, transmembrane 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
RPN2 | Ribophorin II | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
SCAMP4 | Secretory carrier membrane protein 4 | Predicted membrane proteins
| | | | | Expressed in all |
SCAMP5 | Secretory carrier membrane protein 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
SEC63 | SEC63 homolog (S. cerevisiae) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SGMS1 | Sphingomyelin synthase 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
SGMS2 | Sphingomyelin synthase 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A2 | Solute carrier family 1 (glial high affinity glutamate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A4 | Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC1A6 | Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC22A13 | Solute carrier family 22 (organic anion/urate transporter), member 13 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC25A10 | Solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC26A6 | Solute carrier family 26 (anion exchanger), member 6 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC27A5 | Solute carrier family 27 (fatty acid transporter), member 5 | Enzymes Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC38A10 | Solute carrier family 38, member 10 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC41A2 | Solute carrier family 41 (magnesium transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Mixed |